Viatris Inc (VTRS) and Ocuphire Pharma (OCUP) Announce FDA Approval of RYZUMVl Sep 27, 2023 08:02AM
Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agoni Sep 27, 2023 08:00AM
Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agoni Sep 27, 2023 08:00AM